Back to SLNCF
UBS Group AG SLNCF Position History
Silence Therapeutics plc • Healthcare
Quarters held
14
Latest value
$6.6M
Q3 2026
Peak value
$6.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6K |
| Q3 2025 | $1.5M |
| Q3 2025 | $78K |
| Q3 2025 | $31 |
| Q4 2025 | $7K |
| Q4 2025 | $1.2M |
| Q4 2025 | $37K |
| Q4 2025 | $5K |
| Q1 2026 | $6K |
| Q1 2026 | $1.3M |
| Q2 2026 | $13K |
| Q2 2026 | $2.7M |
| Q3 2026 | $46K |
| Q3 2026 | $6.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.6M | 605.5K | — | — |
| Q3 2026 | $46K | 4.2K | — | — |
| Q2 2026 | $2.7M | 242.0K | — | — |
| Q2 2026 | $13K | 1.2K | — | — |
| Q1 2026 | $1.3M | 245.7K | — | — |
| Q1 2026 | $6K | 1.2K | — | — |
| Q4 2025 | $5K | 839 | — | — |
| Q4 2025 | $37K | 6.2K | — | — |
| Q4 2025 | $1.2M | 199.3K | — | — |
| Q4 2025 | $7K | 1.2K | — | — |
| Q3 2025 | $31 | 6 | — | — |
| Q3 2025 | $78K | 15.0K | — | — |
| Q3 2025 | $1.5M | 291.2K | — | — |
| Q3 2025 | $6K | 1.2K | — | — |
Other funds holding SLNCF
$44.5M
$36.4M
$31.6M
$29.4M
$26.9M
$26.6M